Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / OTLK - Investigation of Outlook Therapeutics Inc. (OTLK) Announced by Holzer & Holzer LLC | Benzinga

OTLK - Investigation of Outlook Therapeutics Inc. (OTLK) Announced by Holzer & Holzer LLC | Benzinga

Outlook Therapeutics Inc.

  • ATLANTA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Outlook Therapeutics, Inc. ("Outlook Therapeutics" or "the Company") (NASDAQ:OTLK) complied with federal securities laws. On August 30, 2023, Outlook Therapeutics announced the FDA "issued a CRL to the Company's BLA for ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat wet AMD. While the FDA acknowledged the NORSE TWO pivotal trial met its safety and efficacy endpoints, the Agency concluded it could not approve the BLA during this review ...

    OTLK) Announced by Holzer & Holzer, LLC>Full story available on Benzinga.com

    •
    Stock Information
    Company Name: Outlook Therapeutics Inc.
    Stock Symbol: OTLK
    Market: NASDAQ
    Website: outlooktherapeutics.com
    Menu
    OTLK OTLK Quote OTLK Short OTLK News OTLK Articles OTLK Message Board
    Get OTLK Alerts

    News, Short Squeeze, Breakout and More Instantly...